The precise mechanism of transactivation by phosphoprotein and the role of its phosphorylation status in this process have been the subject of intensive research in the past few years. We have recently cloned and expressed large quantities of phosphate-free P protein in Escherichia coli (2). The VSV transcription reaction mixture reconstituted in vitro with purified L protein, N-RNA template, and unphosphorylated P protein (P0) was found to be defective. Addition of uninfected cell extract to the transcription reaction mixture or prior phosphorylation of the P protein by the cell extract restored transcription, suggesting an essential role of cellular protein kinase-mediated phosphorylation in transcriptional activity of P protein (3). The phosphorylated product (P,) of the cell kinase reaction was further phosphorylated by an L protein-associated kinase to produce the fully phosphorylated form (P2). Thus, it was proposed that complete activation of P protein is mediated through a cascade phosphorylation pathway involving two protein kinase activities-the cell kinase and the L kinase-acting sequentially (3). Substrate specificity and other biochemical parameters ofthe two kinases revealed that they were distinct and different from each other. In this communication, we report the purification and detailed characterization of the cellular protein kinase and show that it is a single enzyme with properties identical to that of cellular casein kinase II (CKII). Phosphorylation of the phosphate-free P protein (PO) by purified CKII and L kinase in vitro fully restored transcriptional activity of P protein.
ent in a wide variety of eukaryotic cells and tissues. Functional VSV transcription could be reconstituted with viral L protein, N-RNA template, and P protein phosphorylated by either purified cellular protein kinase or purified casein kinase Il. The unusual role of casein kinase II in the transcription process of a nonsegmented negative-strand RNA virus would have important implications in host-virus interactions and antiviral therapy.
The transcription complex of vesicular stomatitis virus (VSV), a prototype rhabdovirus, consists of the following: the single-stranded, nonsegmented, and negative-sense (antimessage sense) genome RNA of =11 kilobases, tightly wrapped with the nucleocapsid protein, N (N-RNA template); the large protein, L; and the phosphoprotein, P. The L and P proteins together constitute the viral RNAdependent RNA polymerase that transcribes the N-RNA template to produce viral mRNAs (reviewed in ref. 1) . Genetic and biochemical evidence suggested that L protein may encode the ribonucleotidyl polymerase activity, while phosphoprotein P acts as a transcription factor or a transactivator of the L protein.
The precise mechanism of transactivation by phosphoprotein and the role of its phosphorylation status in this process have been the subject of intensive research in the past few years. We have recently cloned and expressed large quantities of phosphate-free P protein in Escherichia coli (2) . The VSV transcription reaction mixture reconstituted in vitro with purified L protein, N-RNA template, and unphosphorylated P protein (P0) was found to be defective. Addition of uninfected cell extract to the transcription reaction mixture or prior phosphorylation of the P protein by the cell extract restored transcription, suggesting an essential role of cellular protein kinase-mediated phosphorylation in transcriptional activity of P protein (3) . The phosphorylated product (P,) of the cell kinase reaction was further phosphorylated by an L protein-associated kinase to produce the fully phosphorylated form (P2). Thus, it was proposed that complete activation of P protein is mediated through a cascade phosphorylation pathway involving two protein kinase activities-the cell kinase and the L kinase-acting sequentially (3) . Substrate specificity and other biochemical parameters ofthe two kinases revealed that they were distinct and different from each other. In this communication, we report the purification and detailed characterization of the cellular protein kinase and show that it is a single enzyme with properties identical to that of cellular casein kinase II (CKII). Phosphorylation of the phosphate-free P protein (PO) by purified CKII and L kinase in vitro fully restored transcriptional activity of P protein.
MATERIALS AND METHODS
Viral (VSV, New Jersey serotype, Ogden subtype) L protein and N-RNA template and bacterially expressed P protein of the same serotype were purified as described (3) . CKII, purified from bovine testis, was a kind gift from Edwin G. Krebs and David Litchfield (Howard Hughes Institute, Seattle). Oligopeptides were synthesized in a Beckman 990B automated solid-phase peptide synthesizer and purified through HPLC. Dephosphorylated casein, heparin, and protamine were purchased from Sigma. Rabbit anti-human CKII antibody (Upstate Biotechnology, Lake Placid, NY) was raised against a 23-mer synthetic peptide corresponding to residues 70-91 of the a (catalytic) subunit of human CKII coupled to keyhole limpet hemocyanin.
Purification of Po Kinase (PK). The P protein phosphorylating activity (PK) was purified essentially as described for CKII (4) except that the fractions were monitored by their ability to phosphorylate bacterially expressed P protein (PO) as substrate. In brief, the postribosomal supernatant (S100) of baby hamster kidney (BHK) cell extract (10 g of protein) in buffer A [50 mM Tris-HCl, pH 7.5/0.1 mM EDTA/5% (vol/vol) glycerol/0.02% NaN3/1 mM dithiothreitol] containing 50 mM NaCl was loaded onto a 20-ml DEAE-cellulose column. After washing with 60 ml of the same buffer, the column was developed with a linear gradient of 0.1-0.4 M NaCl in buffer A (total vol, 120 ml; collected in 60 fractions). The activity peak (at 'z0.2 M NaCl) was loaded directly onto a 3-ml phosphocellulose column, which was then washed with 6 ml of buffer A plus 0.2 M NaCl and developed with a gradient of 0.2-1.0 M NaCl in buffer A (total vol, 18 ml; collected in 60 fractions). The pooled fractions (at -0.6 M NaCl) were dialyzed against buffer A plus 0.2 M NaCl and rechromatographed onto a second phosphocellulose column (1 ml) in a similar manner. The pooled peak was dialyzed against buffer A plus 10 mM potassium phosphate (pH 7), chromatographed on a 0.5-ml hydroxylapatite (Bio-Rad) column, and finally concentrated by batch elution in hydroxylapatite exactly as described (4 Glu-Thr-Glu-Glu-Glu) was used as substrate (6), 10 ,ul of the reaction mixture was spotted on a 2-cm2 piece of Whatman P81, which was washed five times (=30 min) in 150 mM H3P04, dried, and assayed for 32P radioactivity in a liquid scintillation counter. For peptide P (Glu-Glu-Glu-Ala-SerAsp-Ser-Asp-Ala-Asp), an identical procedure was followed except that the P81 paper was substituted by Whatman DE81 paper, which was carefully washed with 0.5 M Na2HPO4. It was necessary to use a cationic matrix for peptide P since the lack of basic residues in this peptide precluded its binding to the anionic P81 paper (data not shown). However, unreacted
[y-32P]ATP also bound to DE81 and could only be removed by extensive washing with high salt, which also resulted in some loss of the bound peptide (see Table 2 ). Fig. 1 , PK activity eluted in a single peak from DEAE-cellulose and phosphocellulose columns, at about 0.2 and 0.6 M NaCl, respectively. In the final step, PK activity eluted at -0.2 M K2HPO4 from hydroxylapatite (data not shown). The elution of PK activity in a single peak from each of the three matrices strongly suggested the existence of a single protein kinase in the cell that could phosphorylate Po. The profile of each activity peak was essentially similar when dephosphorylated casein was
RESULTS
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.~~~~~~~~~~~~~. used as substrate. These elution parameters and our earlier demonstration that PK activity can utilize both ATP and GTP as phosphate donor (3, 4) suggested that this activity may be very similar to cellular CKII (7). We demonstrate (see below) that the properties of this preparation are indeed identical to those of CKII. Both PK and CKII Phosphorylate Po and Casein. Since PK and CKII were originally purified by using P0 and casein as substrates, respectively, it was important to determine whether the substrates and enzymes could be interchanged. Fig. 2 shows that both protein kinases can phosphorylate both the substrates, although both ofthem phosphorylated Po much more efficiently than casein. Heparin, which inhibits PK in the crude extract (data not shown), inhibited both purified PK and CKII, while protamine stimulated both enzymes -3-fold. Cyclic AMP had no effect on either enzyme activity (data not shown). Essentially identical results were obtained by using casein and Po as substrates in separate kinase reactions (data not shown). We have previously shown that unphosphorylated Po protein elutes from DEAEcellulose at 0.17 M NaCl (3), whereas the product of its phosphorylation by the crude cell extract P1 eluted at 0.27 M NaCl (3). Phosphorylation of P0 by purified PK or CKII in vitro produced a similar chromatographic shift of P protein, indicating that phosphorylation by both enzymes produces a similar structural alteration in P protein.
Biochemical Properties of PK and CKII Are Essentially Identical. Results of a detailed study of the biochemical parameters of the two enzymes, such as Mg2+ optima, apparent Km of ATP and GTP, stimulation by protamine, and inhibition by heparin and 2,3-diphosphoglyceric acid (4, 7), are listed in Table 1 . It is clear that the two enzymes, purified by using different substrates, behave in an identical manner within the limits of experimental variation.
The close identity of the two enzymes was further confirmed by a comparison of their polypeptide profiles. SDS/ PAGE followed by silver staining revealed that both enzymes contain two major classes of polypeptides: larger subunit(s) (aa') in the range of -45 kDa, and a smaller subunit (J3) of -25 kDa (Fig. 3A) . When the enzymes were allowed to autophosphorylate in the absence ofany added substrate, the smaller polypeptides (13) were phosphorylated in both cases (Fig. 3B ). An antibody raised against a synthetic peptide representing the catalytic domain of the a subunit crossreacted with the major 45-kDa doublet of both preparations but did not react with the ,8 subunit of either (Fig. 3C) Of protamine (1 jug/ml)
Stimulates (2-fold) Stimulates (2-fold) Elution properties of CKII were taken from published work (4); all other properties of CKII were determined in this work and the values obtained were comparable to the published ones. Elution profiles of the enzymes were determined by using P0 and casein as substrates for PK (this work) and CKII (4), respectively. All other parameters were measured by using both P0 and casein as substrates (1 and 5 ,ug, respectively, in a standard 20-d kinase reaction mixture) for either enzyme (e.g., as in Fig. 2) ; for a given enzyme, numbers obtained with the two substrates were essentially identical. All kinase reactions were performed under standard reaction conditions in the presence of [y32P]ATP as described except that, where indicated, GTP replaced ATP. Enzyme activities were quantitated by densitometric scanning of a 32P-labeled protein band in the autoradiograph obtained after SDS/PAGE analysis of the kinase reaction. Po>> casein indicates that, at the same concentration and under identical reaction conditions, P0 accepted more phosphates than casein on a mol/mol basis (e.g., see Fig. 2 ). DPG, 2,3-diphosphoglyceric acid.
the acidic domain I (10) of P protein. In addition, phosphoamino acid analyses of viral P protein established serine as the major phosphate acceptor (11, 12) . A comparison of amino acid sequences of P proteins of the New Jersey (NJ) and Indiana serotypes of VSV revealed that a total of five potential phosphate acceptor sites are conserved between residues 35 and 70; in the NJ serotype of P protein, these residues are Thr49, Ser51, Ser59, Ser6l, and Thr63. To determine whether these sites are in fact phosphorylated, we changed these residues to alanine by site-specific mutagenesis (20) . The mutant protein P5 was expressed in E. coli and purified exactly as described for wild-type protein (2) (5) and the gel was silver stained. (B) Autophosphorylation. Enzymes were autophosphorylated in the standard kinase reaction mixture using [y-32P]ATP; the reactions were analyzed by SDS/PAGE followed by autoradiography. (C) Western blot. After SDS/PAGE, the proteins were transferred to a nitrocellulose membrane by electroblotting. The membrane was first probed with a rabbit IgG against synthetic human CKII a peptide and then with peroxidase-conjugated goat anti-rabbit antibody (Boehringer Mannheim) as described (8) . Lane M, protein size standards (kDa).
was then tested in vitro. Results (Fig. 4) showed that the P5 mutant was severely defective in phosphorylation; however, in the same reaction mixture, casein was phosphorylated normally, indicating that the P5 preparation did not contain an inhibitor of kinase activity. To exclude the possibility that it contributed a specific inhibitor of P protein phosphorylation, we included wild-type P protein along with the P5 mutant in the kinase reaction mixture; as shown, this resulted in reappearance of radioactivity in the P protein band. The phosphorylation defect of the P5 mutant strongly implicated one or a few of the five conserved residues as the site(s) of cell kinase (PK)-mediated phosphorylation in P protein. In addition, since both PK and CKII failed to phosphorylate the P5 mutant, it suggested that the two enzymes recognize and phosphorylate the same residues in P protein, which further emphasizes their similarity.
Finally, protein kinases in general are known to phosphorylate short synthetic oligopeptides corresponding to their minimal site of action (13 5) , demonstrating that a cell kinase-free VSV transcription can be reconstituted if the P protein has already been phosphorylated by the cell kinase (3, 14) .
These conclusions were further supported by the finding that heparin, a specific inhibitor of PK and CKII (Fig. 2) , also inhibited transcription reactions programmed with phosphate-free P protein and either of these kinases (Fig. 5, lanes  6 and 7) . At the same concentration, heparin had little effect on L kinase, measured by the ability of the latter to phosphorylate PI (data not shown). As expected, heparin had no effect on transcription reactions that were independent of CKII-i.e., reconstituted with phosphorylated P protein P1 or P2 (lanes 8 and 9) . Protamine, a specific inhibitor of L kinase-mediated phosphorylation of P1 to P2 (3) , inhibited transcription reactions programmed with either P(1 (data not shown) or P1 (lane 10), consistent with an essential role of L kinase in P function. Interestingly, protamine also inhibited transcription reactions programmed with P2, the fully phosphorylated form of P protein (lane 11) . This latter finding suggests that for transcription to progress the P2-specific phosphates, which were shown to undergo a turnover during VSV transcription (3) , must be continually replaced by the L kinase. Taken together, these results and the earlier ones (3, 1 2 3 4 5 6 7 8 9 10 11 FIG. 5. Role of CKII in VSV transcription. In vitro VSV transcriptions (20 pl) were reconstituted by using various purified P proteins (PO, PI, or P2) and host kinase-free N-RNA template and L protein exactly as described (3) . Labeled transcripts were resolved in 6% polyacrylamide gel containing 50% (wt/vol) urea; an autoradiograph of the gel is shown. Where indicated, 10 ng of either protein kinase (PK, lanes 2 and 6; CKtI, lanes 3 and 7) was also included in the reaction mixture. Reaction mixtures h and p received 20 ng of heparin and protamine (both from Sigma), respectively. P protein was the last component added to all reaction mixtures. Various mRNAs are indicated (G, N, P, and M). See Results for details. 15 ) demonstrate that phosphorylation of the P protein by CKII and L kinase is essential for transcriptional activation of the P protein.
DISCUSSION
Our studies of the purified cellular protein kinase that phosphorylates P protein of VSV in vitro show that the enzyme is highly similar, and most likely identical, to CKII. The biological relevance of this identity is evidenced by the demonstration that both enzymes can restore the transcription function of P protein through specific phosphorylation in the acidic domain I of P protein. The unusual role of CKII in activation of a RNA viral phosphoprotein may lead to unique considerations in viral gene regulation and host-virus interaction as discussed below.
CKII is a multipotential, ubiquitous, cyclic AMPindependent serine protein kinase with a number of properties that distinguish it from other protein kinases (see ref. 7 for a comprehensive review). Two such properties-namely, inhibition by heparin and the ability to use both ATP and GTP as phosphate donors-are widely used as diagnostic of CKII. Furthermore, peptide C has been shown to be a specific substrate for CKII and not phosphorylated by other protein kinases (6) such as CKI, protein kinase C, and cyclic AMPdependent protein kinases. As shown here (Tables 1 and 2) , our characterization of the purified P protein kinase as CKII has included all of these criteria. CKIH, purified from a variety of sources, exhibits the general subunit structure a2,32 or aa'[32, with the a and a' subunits having a broad size range of 36-44 kDa, and the subunit being~25 kDa (7) . The a polypeptide binds ATP and possesses some protein kinase activity in the absence of 6, suggesting that it is the catalytic subunit. The /3 subunit, on the other hand, lacks protein kinase activity but undergoes phosphorylation when the holoenzyme is incubated with ATP (4, 7). It appears that CKII of BHK cells, which we have purified by monitoring its P protein phosphorylating activity, has an essentially similar structure (Fig. 3A) . Moreover, upon autophosphorylation, the 25-kDa polypeptide was phos-phorylated (Fig. 3B) . The evolutionary similarity of these enzymes is further underscored by the fact that the aa' doublet in both preparations cross-reacted with anti-human a peptide. A minor polypeptide migrating just below the aa' doublet in CKII but absent in PK could be a proteolytic fragment of a or a'; alternatively, it could represent an extra subunit or a contaminant unique to the bovine enzyme preparation (CKII). CKII is known to require acidic amino acids glutamic or aspartic acid immediately C-terminal (+1 to +3) to the phosphoacceptor serine orthreonine (7, 13) . As shown in Fig.  4 , mutation of five serine and threonine residues between residues 35 and 70 in domain I of P protein resulted in complete abrogation of phosphorylation. An examination of the amino acid sequence in this region reveals that among these five residues, Ser59 and Ser6l are followed (C-terminal side) by acidic residues (aspartic acid) at both the +1 and +3 positions and, therefore, could be optimal sites for CKII phosphorylation. Our recent analyses of the phosphorylation status of various mutant P proteins of the NJ serotype of VSV, expressed in COS cells, have shown that alteration of these two serines to alanines abolishes phosphorylation of P protein (A. Takacs, S.B., T. Das, and A.K.B., unpublished data). Using bacterially expressed mutant P proteins as substrates for purified PK or CKII in vitro, essentially identical results were obtained (unpublished observation). These results and the finding that a peptide containing only these serines as phosphate acceptors is phosphorylated efficiently by PK and CKII in vitro ( Table 2 ) further suggest that CKII is the only cellular protein kinase phosphorylating the P protein. Thus, it appears that the preponderance of acidic amino acids in domain I of P protein serves at least two functions: (i) the acidity may directly contribute to the transactivation property of this domain (16) and (ii) it provides the proper environment for CKII-mediated phosphorylation, which is essential for RNA-dependent RNA transcription.
We have previously shown that phosphorylation of the P protein by cellular kinase is an essential prerequisite to its subsequent phosphorylation by the viral L protein-associated kinase and that only the final, fully phosphorylated form (P2) appears to be transcriptionally active (3) . By replacing the cell extract with purified PK or CKII, we have now obtained identical results (data not shown; Fig. 5 ). This is in conformity with a myriad of similar examples in which phosphorylation by CKII at one site potentiates a neighboring site for phosphorylation or dephosphorylation by other enzymes (17) . Furthermore, phosphates introduced by CKII are relatively stable and undergo very slow turnover (7) . This is in agreement with our earlier observation that phosphate groups of P1, introduced by the cellular kinase, are highly resistant to phosphatases and do not undergo turnover during VSV transcription (3).
The unique role of CKII in RNA viral transcription offers the potential of screening for antiviral drugs through specific inhibition of CKII in vitro. In this connection, the antiviral xanthate compound D609 (tricyclo-decane-9-yl-xanthogenate), an inhibitor of VSV growth in cell cultures, is worth mentioning. The drug strongly inhibited phosphorylation of newly synthesized P protein in VSV-infected cells, with concomitant inhibition of secondary transcription and replication (18) . However, primary transcription-mediated by the input viral ribonucleoprotein containing P protein that is already phosphorylated-remained unaffected. Although it remains to be shown that D609 inhibits CKII in vitro, these results clearly suggest an essential role of the cell kinase(s) in transcriptional activation of P protein in vivo. It would be important to study the effects of heparin and 2,3-diphosphoglycerate on VSV growth to further understand the role of P protein phosphorylation in VSV gene expression in vivo.
Our findings add the P protein of VSV to a large list of regulatory proteins that are phosphorylated by CKII; examples include the human heat shock protein 90, simian virus 40 large tumor antigen, translation initiation and elongation factors, RNA polymerases I and II, and DNA topoisomerases I and II (reviewed in ref. 7) . By utilizing a cellular protein kinase that is widely distributed in eukaryotic cells to incorporate stable phosphate groups in an essential transcription factor, VSV probably ensures the ubiquity of its gene expression in the various host cells that it infects. It remains to be seen whether CKII is one of a variety of protein kinases reported to be packaged in mature vesicular stomatitis virions (1, 19) and whether phosphoproteins of other negative-strand RNA viruses are also phosphorylated by CKII.
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